The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider,

T he first-ever needleless flu vaccine that can be given at home was just approved by the U.S. Food and Drug Administration. FluMist is a nasal spray that provides protection against influenza A and B, and it’s now approved for self-administration in adults up to age 49 and caregiver-administration for kids ages 2 to 17.